## Hypertensive Urgency vs. Emergency: Diagnostic Distinction ### Clinical Recognition This patient has **hypertensive urgency** (BP >180/120 mmHg WITHOUT end-organ damage): - Asymptomatic - Normal renal function (Cr 0.9) - Normal urinalysis (no proteinuria) - Normal fundoscopy (no retinopathy) - Normal ECG (no LVH, no ischemia) **Key Point:** The **absence of end-organ damage** defines urgency, not emergency. Treatment is **oral, not intravenous**. ### Hypertensive Emergency vs. Urgency | Feature | Emergency | Urgency | |---------|-----------|----------| | **BP level** | >180/120 | >180/120 | | **End-organ damage** | **Present** (AKI, retinopathy, encephalopathy, MI, pulmonary edema) | **Absent** | | **Symptoms** | Headache, vision loss, chest pain, dyspnea | Usually asymptomatic | | **Treatment** | **IV vasodilator** (labetalol, nicardipine) | **Oral antihypertensive** | | **BP reduction target** | 10–15% in 1 hour | 25–30% over 24 hours | | **Setting** | ICU/ED | Outpatient or ward | **High-Yield:** The **presence or absence of end-organ damage** is the key discriminator — not the absolute BP number alone. ### Management Algorithm ```mermaid flowchart TD A["BP >180/120 mmHg"]:::outcome --> B{"Signs of end-organ damage?"}:::decision B -->|"Yes: AKI, retinopathy, neuro, cardiac, pulmonary edema"| C["Hypertensive Emergency"]:::urgent B -->|"No: normal exam, normal labs, normal ECG, normal urine"| D["Hypertensive Urgency"]:::outcome C --> E["IV vasodilator: labetalol or nicardipine"]:::action E --> F["Target: 10-15% reduction in 1 hour"]:::action D --> G["Oral antihypertensive: amlodipine, lisinopril, atenolol"]:::action G --> H["Follow-up in 2-4 weeks"]:::action H --> I["Titrate to target <140/90 mmHg"]:::action ``` ### Why Oral Therapy? **Clinical Pearl:** Hypertensive urgency **does not require IV therapy**. Oral agents are: - Safer (no risk of overshoot hypotension) - Effective (BP reduction over 24–48 hours) - Appropriate for outpatient management Common first-line agents: - **Amlodipine** (dihydropyridine CCB): onset 30–60 min, duration 24 hrs - **Lisinopril** (ACE inhibitor): onset 1–2 hrs, duration 24 hrs - **Atenolol** (β-blocker): onset 1–2 hrs, duration 24 hrs **Tip:** Choose based on comorbidities (e.g., ACE inhibitor if diabetic, β-blocker if post-MI). ## Why This Answer Oral antihypertensive therapy with 2–4 week follow-up is the **standard of care** for hypertensive urgency. IV therapy is **not indicated** when end-organ damage is absent.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.